Michael Ryskin
Stock Analyst at B of A Securities
(1.45)
# 3,480
Out of 5,182 analysts
41
Total ratings
52%
Success rate
-2.6%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXRX Recursion Pharmaceuticals | Maintains: Neutral | $7 → $6 | $3.41 | +75.95% | 3 | Feb 26, 2026 | |
| ZTS Zoetis | Maintains: Neutral | $135 → $140 | $116.65 | +20.02% | 8 | Feb 13, 2026 | |
| SDGR Schrödinger | Upgrades: Buy | $24 | $12.24 | +96.08% | 3 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Buy | $110 → $99 | $85.18 | +16.22% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $51.10 | +36.99% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $568.30 | -16.42% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.56 | +125.04% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $177.28 | +16.20% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $83.09 | -51.86% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $0.73 | +1,195.69% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $6.14 | +290.88% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $7.86 | +205.34% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $4.86 | +105.76% | 2 | Nov 10, 2021 |
Recursion Pharmaceuticals
Feb 26, 2026
Maintains: Neutral
Price Target: $7 → $6
Current: $3.41
Upside: +75.95%
Zoetis
Feb 13, 2026
Maintains: Neutral
Price Target: $135 → $140
Current: $116.65
Upside: +20.02%
Schrödinger
Dec 15, 2025
Upgrades: Buy
Price Target: $24
Current: $12.24
Upside: +96.08%
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $85.18
Upside: +16.22%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $51.10
Upside: +36.99%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $568.30
Upside: -16.42%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.56
Upside: +125.04%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $177.28
Upside: +16.20%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $83.09
Upside: -51.86%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $0.73
Upside: +1,195.69%
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $6.14
Upside: +290.88%
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $7.86
Upside: +205.34%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $4.86
Upside: +105.76%